DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues

Anticancer Research

Volumn 18, Issue 3 A, 1998, Pages 1677-1682

  Barletta, Anna ^a   Marzullo, Franco ^a   Pellecchia, Antonio ^a   Montemurro, Severino ^a   Labriola, Angela ^a   Lomonaco, Rocco ^a   Grammatica, Luciano ^a   Paradiso, Angelo ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Colon cancer; Flow cytometry; p53; PCNA

Indexed keywords

CYCLINE; DNA; MONOCLONAL ANTIBODY; PROTEIN P53;

ANEUPLOIDY; ARTICLE; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CANCER; COLON POLYP; DNA CONTENT; DYSPLASIA; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PLOIDY; PRECANCER; PRIORITY JOURNAL;

EID: 0031825506     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Fearon E and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-67, 1990.
2. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991.
3. Cho KR, Vogelstein B: Genetic alterations in the adenoma-carcinoma sequence. Cancer 70: 1727-1731, 1992.
4. Bishop DT and Hall NR: The genetics of colorectal cancer. Eur J Cancer 30A: 1946-1955, 1994.
5. Greenblatt MS, Bennett WP, Hollstein M and Harris CC: Mutations of the p53 tumour suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994.
6. McIlwrath AJ, Vasey PA, Ross GM and Brown R: Cell cycle arrest and radiosensitivity of human tumor cell lines: dependence on wildtype p53 for radiosensitivity. Cancer Res 54: 3718-3722, 1994.
7. Stewart N, Hicks GG, Paraskevas F, Mowat M: Evidence for a second cell cycle clock at G2/M by p53. Oncogene 10: 109-115, 1995.
8. Baker SJ, Preisinger AC, Jessus JM, Paraskeva C, Makowitz S, Wilson JKV, Hamilton S and Vogelstein B: p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50: 7717-7722, 1990.
9. Carder PJ, Cripps KJ, Morris R, Collins S, White S, Bird CC and Wyllie AH: Mutation of the p53 gene precedes aneuploid clonal divergence in colorectal carcinoma. Br J Cancer 71: 215-218, 1995.
10. Pavelic ZP, Pavelic L, Kuvelkar R and Gapany SR: High c-myc protein expression in benign colorectal lesions correlates with the degree of dysplasia. Anticancer Res 12: 171-176, 1992.
11. Moerkerk P, Arends JW, van Driel M, de Bruine A, de Goeij A and ten Kate J: Type and number of Ki-ras point mutations relate to stage of human colorectal cancer. Cancer Res 54: 3376-3378, 1994.
12. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P and Vogelstein B: Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256: 102-105, 1992.
13. Sun X-F, Carstensen JM, Stal O, Zhang H and Nordenskjold B: Proliferating cell nuclear antigen (PCNA) in relation to ras, c-erbB-2, p53, clinico-pathological variables and prognosis in colorectal adenocarcinoma. Int J Cancer 69: 5-8, 1996.
14. Linden MD, Chan K, Kubus J, Brown RD and Zarbo RJ: Ki-67 and proliferating cell nuclear antigen tumor proliferative indices in DNA diploid colorectal adenocarcinomas. Correlation with histopathologic characteristics and cell cycle analysis with two-color DNA flow-cytometry. Am J Clin Pathol 100: 206-213, 1993.
15. Faranda A, Costa A, Silvestrini R, Quagliolo V and Gennari L: S-phase cell fraction in the prognosis of Dukes' stage D colorectal carcinoma. Cell Proliferation 27: 561-569, 1994.
16. Hall PA, Levison DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA, Barnes DM, Gillet CE, Camplejohn R, Dover R, Waseem NH and Lane DP: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 285-294, 1990.
17. Jass JR and Sobin LH: Histological typing of intestinal tumours. In World Health Organization International Histological Classification of Tumours (ed 2) Springer-Verlag, Berlin, pp 32-33, 1989.
18. Hermanek P and Sobin LH (eds). UICC TMN classification of malignant tumours. (ed 4) Springer-Verlay, Berlin, pp. 47-49, 1987.
19. Cripps KJ, Purdie CA, Carder PJ, White S, Komine K, Bird CC and Wylie AH: A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma. Oncogene 9: 2739-2743, 1994.
20. Paradiso A, Barletta A, Prete F, Pellecchia A, Romagno D, Lucchese G, Benvestito V, Zito FA, Russo S and De Lena M: Flow Cytometry DNA content and morphobiological characteristics in chronic and neoplastic human liver disease. Ital J Gastroenterol 27: 8-12, 1995.
21. Tirindelli Danesi D, Spano' M and Altavista P: Quality control of the the Italian group of cytometry on flow cytometry cellular DNA content measurements. Cytometry 14: 576-586, 1993.
22. Lazaris AC, Davatris P, Nakopoulo L, Theodoropoulos GE, Koullias G and Golematis BC: Correlation between immunohistochemical expression of proliferating cell nuclear antigen and flow cytometry parameters in colorectal neoplasia. Dis Colon Rectum 37: 1083-1089, 1994.
23. Bauer KD, Bagwell CB, Giaretti W, Melamed M, Zarbo RJ, Witzig TE and Rabinovitch PS: Consensus Review of the clinical utility of DNA Flow Cytometry in colorectal cancer. Cytometry 14: 486-491, 1993.
24. Bottger TC, Potratz D, Stockle M, Wellek S, Klupp J and Junginger T. Prognostic value of DNA analysis in colorectal carcinoma. Cancer 72: 3579-3587, 1993.
25. Giaretti W and Santi L: Tumor progression by DNA flow cytometry in human colorectal cancer. Int J Cancer 45: 597-603, 1990.
26. Teixeria CR, Tanaka S, Haruma K, Yoshihara MS and Kajiyama G: Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas. Cancer 73: 575-579, 1994.
27. Kovac D, Rubinic M, Krasevic M, Krizanac S, Petrovecku BM, Stimac D and Melato M: Proliferating cell nuclear antigen (PCNA) as a prognostic factor for colorectal cancer. Anticancer Res 15: 2301-2302, 1995.
28. Nakae S, Nakamura T, Shirono J, Yoshioka H, Ikegawa R, Miyamura K, Kawasaki K, Saitoh Y and Tabuchi Y: Analysis of proliferative activity using antiproliferating cell nuclear antigen antibody in colorectal cancer. J Surg Oncol 60(3): 149-153, 1995.
29. Goh H-S, Chan C-S, Khine KS and Mith DR: p53 and behaviour of colorectal cancer. Lancet 344: 233-234, 1994.
30. Yao T, Utsunomiya T, Nagai E, Oya M and Tsuneyoshi M: p53 expression patterns in colorectal adenomas and early carcinomas: A special reference to depressed adenoma and non-polypoid carcinoma. Path Int 46: 962-967, 1996.
31. Bosari S, Viale G, Bossi P, Maggioni M, Coggi G, Murray KK and Lee AKC: Cytoplasmic accumulation of p53 protein: An independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst 86: 681-687, 1994.
32. Kern SE: p53 tumor suppression through control of the cell cycle. Gastroenterol 106: 1708-1711, 1994.
33. Kaklamanis L, Gatter KC, Mortensen N, Baigrie RJ, Heryet A, Lane DP and Harris AL: p53 Expression in colorectal adenomas. Am J Pathol 142(1): 87-93, 1993.
34. Sameshima S, Kubota Y, Sawada T, Watanabe T, Kuroda T, Tsuno N, Higuchi Y, Shinozaki M, Sunouchi K, Masaki T, Saito Y and Muto T: Overexpression of p53-Protein and histologic grades of dysplasia in colorectal adenomas. Dis Colon Rectum 39: 562-567, 1996.
35. Pignatelli M, Stamp GWH, Kafiri G, Lane D and Bodmer WF: Overexpression of p53 nuclear oncoprotein in colorectal adenomas. Int J Cancer 50: 683-688, 1992.
36. Ozdamar SO, Ozyilkan E, Ozyilkan O and Kandemir B: The correlation between p53 tumor suppressor gene and proliferating cell nuclear antigen expression in colorectal adenocarcinoma. Pathol Int 45: 973-974, 1995.
37. Paradiso A, Rabinovich M, Vallejo C, Machiavelli M, Romero A, Perez J, Lacava J, Cuevas MA, Rodriquez R, Leone B, Sapia MG, Simone G and De Lena M: p53 and PCNA expression in advanced colo-rectal cancer: response to chemotherapy and long term prognosis. Int J Cancer 69: 437-441, 1996.
38. Lanza G Jr, Maestri I, Dubini A, Gafa VR, Santini A, Ferretti S and Cavazzini L: p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern, and short-term survival. Am J Clin Pathol 105: 604-612, 1996.